Department of Heart Disease, Haukeland University Hospital, Bergen, Norway.
Department of Health and Caring Sciences, Western Norway University of Applied Sciences, Bergen, Norway.
Heart Lung Circ. 2021 Aug;30(8):1221-1231. doi: 10.1016/j.hlc.2020.10.024. Epub 2021 Mar 10.
Frailty status and patient-reported outcomes are especially pertinent in octogenarians following transcatheter aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR) to guide treatment decisions and promote patient-centred care.
We aimed to determine if frailty changed 6 months after aortic valve replacement (AVR) in octogenarians, and to describe changes in self-rated health according to frailty status in patients who underwent TAVI or SAVR.
In a prospective cohort study, frailty and self-rated health were measured one day prior to and 6 months after AVR. Frailty status was measured with the Study of Osteoporotic Fracture index. Self-rated health was measured comprehensively with the disease-specific Minnesota Living with Heart Failure Questionnaire, the generic Medical Outcomes Study Short Form-12 questionnaire (SF-12), and two global questions from The World Health Organization Quality of Life Instrument Abbreviated.
Data were available for 143 consecutive patients (mean age 83±2.7 years, 57% women; 45% underwent TAVI). At baseline, 34% were robust, 27% prefrail, and 39% frail. Overall, there was no change in the distribution of frailty status 6 months after baseline (p=0.13). However, on an individual level 65 patients changed frailty status after AVR (40 patients improved and 25 declined). Improvement in frailty status was common in prefrail (33%; n=13) and frail patients (48%; n=27). Patients had improved self-rated health after AVR, with significant differences between frailty states both at baseline (SF-12 physical: 37.4 [robust], 33.1 [prefrail], 31.6 [frail], p=0.03); SF-12 mental: 51.9 [robust], 50.8 [prefrail], 44.5 [frail], p<0.001); and at the 6-month follow-up (SF-12 physical: 45.4 [robust], 38.3 [prefrail], 32.1 [frail], p<0.001); SF-12 mental: 54.9 [robust], 49.6 [prefrail], 46.8 [frail], p=0.002).
Advanced treatment performed in a high-risk population allowed people to improve their self-rated health. Although frailty is associated with poor self-rated health, frailty status does not equal negative outcomes. The frail patients were those who improved most in self-rated physical and mental health. They had the lowest baseline self-rated health scores and had therefore the most to gain.
在 80 岁以上接受经导管主动脉瓣置换术(TAVI)和外科主动脉瓣置换术(SAVR)的患者中,虚弱状态和患者报告的结局尤其重要,可用于指导治疗决策并促进以患者为中心的护理。
我们旨在确定 80 岁以上患者在主动脉瓣置换术(AVR)后 6 个月时是否会出现虚弱状态变化,并描述在接受 TAVI 或 SAVR 的患者中,根据虚弱状态自我评估健康状况的变化。
在一项前瞻性队列研究中,在 AVR 前一天和 6 个月后测量虚弱和自我评估健康状况。使用骨质疏松性骨折研究指数测量虚弱状态。自我评估健康状况通过特定疾病的明尼苏达州心力衰竭生活质量问卷、通用医疗结果研究简表-12 问卷(SF-12)和世界卫生组织生活质量量表简表的两个全球问题进行全面测量。
共有 143 名连续患者的数据可用(平均年龄 83±2.7 岁,57%为女性;45%接受了 TAVI)。基线时,34%为健壮,27%为虚弱前期,39%为虚弱。总体而言,基线后 6 个月虚弱状态的分布没有变化(p=0.13)。然而,在个体水平上,有 65 名患者在 AVR 后出现了虚弱状态变化(40 名患者好转,25 名患者恶化)。虚弱前期(33%;n=13)和虚弱患者(48%;n=27)的虚弱状态改善常见。患者在 AVR 后自我评估健康状况得到改善,在虚弱状态之间存在显著差异,基线时(SF-12 身体:37.4[健壮]、33.1[虚弱前期]、31.6[虚弱],p=0.03);SF-12 心理:51.9[健壮]、50.8[虚弱前期]、44.5[虚弱],p<0.001)和 6 个月随访时(SF-12 身体:45.4[健壮]、38.3[虚弱前期]、32.1[虚弱],p<0.001);SF-12 心理:54.9[健壮]、49.6[虚弱前期]、46.8[虚弱],p=0.002)。
在高危人群中进行的高级治疗使人们能够改善自我评估的健康状况。尽管虚弱与较差的自我评估健康状况相关,但虚弱状态并不等于负面结果。虚弱的患者在自我评估的身体和心理健康方面改善最多。他们的基线自我评估健康评分最低,因此受益最大。